Equity intelligence report • June 03, 2026
Walgreens Boots Alliance has reached a $683 million settlement with Florida regarding opioid-related claims, exacerbating its financial woes after a sharp year-over-year decline in earnings from $1.1 billion to $289 million. The company is struggling due to decreasing pharmacy sales and COVID-19 impacts while pivoting towards healthcare services through strategic acquisitions like VillageMD and Shields. Despite a brief period of hope with analysts upgrading its stock, Walgreens' aggressive healthcare expansion and continuous financial challenges highlight its ongoing transformation amidst a volatile market environment.
Click a month on the chart to update the report below.